01 December 2007
Evaluating co-medication and matrix interference inï¬‚uence on ion yields: A key step in therapeutic drug monitoring HPLC-MS/MS assay validationC. Seger, M. Bock, K. Tentschert, A. Griesmacher
Ann Transplant 2008; 13(1): 38-38 :: ID: 880198
Background: A HPLC-MS/MS assay can outperform immunoassays in TDM due to its increased accuracy (no cross-reactivity with target analyte congeners), sensitivity, and precision. Sudden and unpredictable ion yield attenuation, often only known as "ion suppression effect" can be considered as one central analytical problem of using MS/MS as detector in bio-analysis. Since pathological patient specimen compositions or co-medications are major causes for these effects, measures have to be taken to evaluate these interferences prior to transferring an HPLC-MS/MS assay to routine use.
Material/Methods: A fully validated online SPE-HPLC-MS/MS assay setup (MS: API4000QTrap, SPE column: Oasis HLB, HPLC column: XDB-C-18, 1:20 sample dilution, cycle time 3.5 min) designed for fast routine immunosuppressant TDM was used. Post column infusion or drug spiking experiments were performed. A total of 54 drugs as well as icteric, haemolytic, and lipaemic blank matrices have been screened.
Results: Infusion experiments showed only little inï¬‚uence of the spiked drugs on the analyte ion profiles, whereas spiking experiments unveiled strong signal suppression or enhancement in many cases. For cyclosporine A/tacrolimus the internal standards cyclosporine D/ascomycin balanced the effects, whereas some significant changes were observed for sirolimus and everolimus using either 32-desmethoxyrapamycin or ascomycin as co-eluting internal standards. Pathologically altered matrices did not distinctly inï¬‚uence quantitative results
Conclusions: Even if using highly diluted samples and state of the art 2D chromatography, co-medication can cause ion yield attenuation effects in fast routine TDM. Optimal internal standards are needed to balance such effects.
Keywords: immunosuppressant, Cyclosporine, Tacrolimus
04 Aug 2022 : Original articleLong-Term Patency of All-in-One Sleeve Patch Graft Venoplasty in 16 Patients Who Underwent Living Donor Liv...
Ann Transplant In Press; DOI: 10.12659/AOT.936888
22 Jul 2022 : Original articleDiagnostic Role of Tumor Markers for Hepatocellular Carcinoma in Liver Transplantation Candidates: An Analy...
Ann Transplant In Press; DOI: 10.12659/AOT.936937
22 Jul 2022 : Original articleDevelopment of a Novel Model for Predicting Postoperative Short-Term Outcome in Patients with Hepatitis B-R...
Ann Transplant In Press; DOI: 10.12659/AOT.936732
Most Viewed Current Articles
26 Jan 2022 : Review articleRecurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models
Ann Transplant 2022; 27:e934924
29 Dec 2021 : Original articleEfficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...
Ann Transplant 2021; 26:e933588
24 Jul 2020 : Review articleKidney Transplantation in the Times of COVID-19 – A Literature Review
Ann Transplant 2020; 25:e925755